• Wed, November 11, 2020
  • Thu, November 12, 2020

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $50 on, Nov 11th, 2020

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $68 to $50 on, Nov 11th, 2020.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Luchini of "BMO Capital" Downgraded from Buy to Hold and Held Target at $56 on, Thursday, November 5th, 2020


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $81 on, Thursday, November 5th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $99 on, Thursday, November 5th, 2020
  • Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $123 on, Tuesday, October 20th, 2020